Drug Information

Drug General Information
Drug ID
D0S0EQ
Former ID
DIB013717
Drug Name
AZD-0865
Synonyms
AR-H044277
Drug Type
Small molecular drug
Indication Gastrointestinal disease [ICD10:K00-K93] Phase 2 [521710]
Company
AstraZeneca plc
Formula
C21H26N4O2
Canonical SMILES
c12n(cc(cc1NCc1c(cccc1C)C)C(=O)NCCO)c(c(n2)C)C
PubChem Compound ID
9951066
Target and Pathway
Target(s) H+ K+ ATPase Target Info Modulator [528510]
References
Ref 521710ClinicalTrials.gov (NCT00206284) A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients Without Erosive Esophagitis.. U.S. National Institutes of Health.
Ref 528510Mechanism of action of AZD0865, a K+-competitive inhibitor of gastric H+,K+-ATPase. Biochem Pharmacol. 2007 Jan 15;73(2):198-205. Epub 2006 Sep 24.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.